EVOLVE

Evocalize Unveils New Localized Marketing Capabilities with Generative AI

Retrieved on: 
Thursday, May 11, 2023
Generative, Synthetic media, Artificial intelligence, ROI, Human, EVOLVE, Machine learning, Marketing, Mobile phone, Information technology, Evocation

AUSTIN, May 11, 2023 /PRNewswire/ -- Evocalize , the provider of industry-leading technology that powers many of the largest, most effective cross-channel digital marketing solutions, proudly announces the addition of Generative AI Ad Copy to EVOLVE — its cutting-edge suite of intelligent marketing capabilities.

Key Points: 
  • AUSTIN, May 11, 2023 /PRNewswire/ -- Evocalize , the provider of industry-leading technology that powers many of the largest, most effective cross-channel digital marketing solutions, proudly announces the addition of Generative AI Ad Copy to EVOLVE — its cutting-edge suite of intelligent marketing capabilities.
  • "Our generative AI capabilities give franchisees the ability to quickly tailor their marketing programs to their local customers and prospects without needing to become marketing experts to write compelling messaging.
  • EVOLVE generative AI is your data-driven local marketing expert."
  • For more information on Evocalize's Collaborative Marketing Platform and its EVOLVE suite of intelligent marketing capabilities, visit evocalize.com .

Melodie Secures New Funding at $15m Valuation

Retrieved on: 
Friday, April 28, 2023
Karma, NAB, Music, Ice, Armed, API, TV, Indigenous Australians, LTM, VOD, ARIA, Sasuke (TV series), Traction, Investment, First Nations, Growth, UGC, EVOLVE, The Real Housewives, Mélodie, Atlassian

SYDNEY, April 28, 2023 /PRNewswire/ -- Fast-growing music licensing platform Melodie has secured new funding at a $15 million valuation, surging up from the last raise valuation of $4 million in September 2021 .

Key Points: 
  • SYDNEY, April 28, 2023 /PRNewswire/ -- Fast-growing music licensing platform Melodie has secured new funding at a $15 million valuation, surging up from the last raise valuation of $4 million in September 2021 .
  • Melodie is achieving significant growth by expanding its music API licensing revenue base, bringing in new composers and music tracks, and placing its catalogue in more film & TV productions.
  • Melodie platformed music is now heard around the world and boasts more than 2 million minutes of music broadcast on free-to-air and VOD platforms in Australia alone.
  • Evan Buist says, "The demand from our clients to license authentic music from First Nations artists has never been greater.

EvolveImmune Therapeutics Reports First Results from CRISPR-Cas9 T Cell Exhaustion Screening Platform at American Association for Cancer Research (AACR) Annual Meeting 2023

Retrieved on: 
Tuesday, April 18, 2023
CD2, CRISPR, Bladder cancer, AACR, B-cell lymphoma, Therapy, Immunology, CD3, CD70, CD28, Gene editing, Pharmacokinetics, American Association for Cancer Research, RNA, Research, BATF, FAS, CD8, Animal, PD-1, Gene, PD-L1, EVOLVE, Vaccine

BRANFORD, Conn., April 18, 2023 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, an immuno-oncology company developing first-in-category, multifunctional biotherapeutics to overcome cancer-driven immunodeficiency, today announced the presentation of the first data highlighting the company’s proprietary CRISPR-Cas9 T cell exhaustion screening platform. Additionally, the company presented the latest preclinical data for EV-104, the company’s first-in-category lead solid tumor program which was created using the company’s proprietary costimulatory T cell engager platform, known as EVOLVE. These presentations were delivered at the American Association for Cancer Research (AACR) Annual Meeting 2023, which is being held April 14-19, 2023, in Orlando, Florida.

Key Points: 
  • These presentations were delivered at the American Association for Cancer Research (AACR) Annual Meeting 2023, which is being held April 14-19, 2023, in Orlando, Florida.
  • In a poster presentation, the company introduced a novel CRISPR-Cas9 T cell exhaustion screen that it designed to identify molecular targets that regulate T cell exhaustion following chronic T cell receptor and CD28 costimulatory receptor activation.
  • EvolveImmune scientists utilized this screen to identify specific genes that promote T cell exhaustion, which are associated with different signaling and regulatory pathways than the PD-1/PD-L1 checkpoint pathway.
  • “We are excited to unveil our T cell exhaustion screening platform for the first time.

Evocalize Expands Local Digital Marketing Capabilities to Google Display Network and YouTube

Retrieved on: 
Tuesday, April 4, 2023
History, Gmail, Google Ads, Machine learning, Algorithm, Artificial intelligence, EVOLVE, Behavior, Mobile phone, Evocation (band)

SEATTLE, April 4, 2023 /PRNewswire/ -- Evocalize, the provider of industry-leading technology that powers many of the largest, most effective cross-channel digital marketing solutions, is excited to announce its expansion of local digital marketing capabilities into Google Display Network and YouTube, allowing users to reach the 800 million active users across all of Google's applications.

Key Points: 
  • SEATTLE, April 4, 2023 /PRNewswire/ -- Evocalize , the provider of industry-leading technology that powers many of the largest, most effective cross-channel digital marketing solutions, is excited to announce its expansion of local digital marketing capabilities into Google Display Network and YouTube, allowing users to reach the 800 million active users across all of Google's applications.
  • This new addition empowers franchisees and local operators to launch full-funnel, multi-channel local marketing programs over Google Search, Google Display Network, YouTube, Facebook, Instagram and TikTok — all in a couple clicks on Evocalize's Collaborative Marketing Platform.
  • "Adding these new channels to our offering is a huge win for franchisees," says Matthew Marx, CEO of Evocalize.
  • It's never been easier for non-marketers to compete in the complex world of local digital marketing with sophisticated turnkey full-funnel digital marketing programs that drive real performance."

Evocalize Partners with Side to Power Digital Marketing Campaigns for Top Boutique Real Estate Companies

Retrieved on: 
Wednesday, March 22, 2023
Insurance, MLS, Evocation, Partnership, Travel, Marketing, Restaurant, Machine learning, Algorithm, EVOLVE, Automation, Sales

Together, Evocalize and Side are drastically improving the way real estate agents approach local digital marketing on Google, Facebook, and Instagram by allowing the most sophisticated lead generation programs to be launched with push-button ease.

Key Points: 
  • Together, Evocalize and Side are drastically improving the way real estate agents approach local digital marketing on Google, Facebook, and Instagram by allowing the most sophisticated lead generation programs to be launched with push-button ease.
  • The partnership allows Side to offer its network of market-leading boutiques a powerful new tool for reaching and engaging their target audiences.
  • Evocalize's technology supports businesses across industries, including residential and commercial real estate, mortgage, insurance, senior living, financial services, restaurants, franchises, travel and more.
  • With Side's expertise and Evocalize's innovative technology, boutique companies in Side's network can now reach their growth targets more effectively and efficiently than ever before.

EvolveImmune Therapeutics Presents New Preclinical Data Demonstrating Improved Anti-Tumor Potential of Novel Costimulatory T Cell Engager Platform at Festival of Biologics Immunotherapy World Congress

Retrieved on: 
Wednesday, March 22, 2023
Monoclonal antibody, Lymphoid leukemia, CD2, Immunology, Therapy, CD3, CD28, CD20, Neoplasm, Cancer, Research, Immunotherapy, Acute myeloid leukemia, CD8, Festival, Lymphocyte, EVOLVE, Pharmaceutical industry, Vaccine

BRANFORD, Conn., March 22, 2023 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, an immuno-oncology company developing first-in-category, multifunctional biotherapeutics to overcome cancer-driven immunodeficiency, today announced that new preclinical data on EVOLVE™, the company’s novel costimulatory T cell engager platform, were featured in an oral presentation at the Festival of Biologics Immunotherapy World Congress. The presentation highlighted the potential of the company’s innovative integrated CD2 costimulatory strategy to overcome treatment limitations of current immunotherapies. Additionally, the company disclosed the first data for EVOLVE-105, its best-in-class CD20xCD3 multispecific T cell engager that also selectively mediates CD2 costimulation.

Key Points: 
  • The presentation highlighted the potential of the company’s innovative integrated CD2 costimulatory strategy to overcome treatment limitations of current immunotherapies.
  • Additionally, the company disclosed the first data for EVOLVE-105, its best-in-class CD20xCD3 multispecific T cell engager that also selectively mediates CD2 costimulation.
  • Moreover, they do not provide coordinated costimulatory receptor activation to overcome T cell dysfunction and drive more effective and longer lasting anti-tumor responses.
  • The Festival of Biologics presentation, entitled, “A novel costimulatory T cell engager platform engineered for the treatment of immune suppressive tumors,” included key new findings for the company’s EVOLVE platform and its growing costimulatory T cell engager portfolio.

Cabot Corporation Launches EVOLVE™ Sustainable Solutions Technology Platform Focused on Advancing Sustainable Reinforcing Carbons

Retrieved on: 
Tuesday, March 21, 2023
Automotive Manufacturing, Manufacturing, Batteries, Technology, Chemicals, Plastics, Carbon, International Sustainability Alliance, Newsweek, ASTM, IBD, Cabot Corporation, Platinum, Table tennis rubber, GHG, Multimedia, ISCC, N550, NYSE, Plant, Cabot, Corporation, Pyrolysis, EVOLVE, CO2, Renewable energy, Engineered wood, Recycling, Tire manufacturing

Cabot Corporation (NYSE: CBT) today announced the launch of EVOLVE™ Sustainable Solutions, a new technology platform for advancing sustainable reinforcing carbons.

Key Points: 
  • Cabot Corporation (NYSE: CBT) today announced the launch of EVOLVE™ Sustainable Solutions, a new technology platform for advancing sustainable reinforcing carbons.
  • View the full release here: https://www.businesswire.com/news/home/20230321005243/en/
    Increased environmental pressures are driving greater demand for sustainable reinforcing carbon solutions that support a circular, sustainable economy as well as decrease GHG emissions.
  • The introduction of EVOLVE Sustainable Solutions is an important step in Cabot’s journey to develop new ways to create materials that improve daily life and enable a more sustainable future.
  • Cabot has launched two new products powered by EVOLVE Sustainable Solutions under the recovered category, VULCAN® 7H-C circular reinforcing carbon and STERLING® SO-RC110 circular reinforcing carbon that will leverage an ISCC PLUS certified mass balance approach.

DBV Technologies Reports Full Year 2022 Financial Results and Business Update

Retrieved on: 
Thursday, March 2, 2023
GAAP, Caregiver, Form 10-K, Form, Cash and cash equivalents, European, Use, International, BLA, Bank statement, DBV Technologies, DBV, Audit, EVOLVE, Cash, Euronext

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today reported financial results for the full year 2022.

Key Points: 
  • DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today reported financial results for the full year 2022.
  • DBV completed EVOLVE, a 12-week caregiver and patient user experience study of the modified Viaskin Peanut patch in 50 peanut allergic children ages 4 – 11-years old.
  • Unless otherwise indicated, the financial figures in the Full Year 2022 Financial Highlights are presented under both U.S GAAP and IFRS financial statements, and commented using U.S. GAAP financial statements.
  • Differences between US GAAP and IFRS consolidated financial statements are mainly due to discrepancies arising from the application of lease accounting standards.

Evocalize Wins Coveted HousingWire Tech100 Awards in Two Categories

Retrieved on: 
Thursday, March 2, 2023
Housing, Organization, ROI, Marketing, Real estate, EVOLVE, Artificial intelligence, Mobile phone, Evocation (band)

SEATTLE, March 2, 2023 /PRNewswire/ -- Evocalize , the provider of industry-leading technology that powers many of the largest, most effective cross-channel local digital marketing solutions, is excited to announce being selected by HousingWire as a winner of their coveted Tech100 award in two major categories — Mortgage and Real Estate.

Key Points: 
  • SEATTLE, March 2, 2023 /PRNewswire/ -- Evocalize , the provider of industry-leading technology that powers many of the largest, most effective cross-channel local digital marketing solutions, is excited to announce being selected by HousingWire as a winner of their coveted Tech100 award in two major categories — Mortgage and Real Estate.
  • The Tech100 program provides housing professionals with a comprehensive list of the most innovative and impactful organizations.
  • This year also marks the first year Evocalize has received the Tech100 award in the Mortgage industry.
  • "We're very excited and honored to have been selected this year by HousingWire to receive these two awards," says Matthew Marx, CEO of Evocalize.

Evocalize Introduces EVOLVE Artificial Intelligence, the Next Evolution in Digital Marketing

Retrieved on: 
Friday, February 24, 2023
Marketing, AI, EVOLVE, ROI, Artificial intelligence, Machine learning, Retail, Evocation (band)

EVOLVE will also apply real-time local media mix optimizations, automatically maximizing performance and ROI across multiple digital marketing channels.

Key Points: 
  • EVOLVE will also apply real-time local media mix optimizations, automatically maximizing performance and ROI across multiple digital marketing channels.
  • "With EVOLVE, we're launching the next evolution of local marketing capabilities with extremely powerful features serving as a sophisticated, personalized co-pilot that will change the way people approach local digital marketing.
  • We're excited to see how the EVOLVE suite of AI and machine learning powered capabilities will transform the digital marketing landscape, and fuel the evolution of how we approach local marketing."
  • EVOLVE is the next evolution in local digital marketing, and is designed to save time, maximize efficiency, and improve ROI for anyone marketing across digital channels, such as Google, TikTok, Facebook and Instagram.